146 related articles for article (PubMed ID: 23408530)
1. Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.
Maeland JA; Radtke A; Lyng RV; Mavenyengwa RT
Clin Vaccine Immunol; 2013 Apr; 20(4):607-12. PubMed ID: 23408530
[TBL] [Abstract][Full Text] [Related]
2. Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.
Mavenyengwa RT; Maeland JA; Moyo SR
Clin Vaccine Immunol; 2009 Sep; 16(9):1302-8. PubMed ID: 19587152
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Z and R3 antigen expression and of genes encoding other antigenic markers in invasive human and bovine Streptococcus agalactiae strains from Norway.
Maeland JA; Radtke A
Vet Microbiol; 2013 Dec; 167(3-4):729-33. PubMed ID: 24120184
[TBL] [Abstract][Full Text] [Related]
4. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.
Moyo SR; Maeland JA; Bergh K
J Med Microbiol; 2002 Jul; 51(7):595-662. PubMed ID: 12132777
[TBL] [Abstract][Full Text] [Related]
5. Properties and distribution of the putative R3 protein of Streptococcus agalactiae.
Kvam AI; Bevanger L; Maeland JA
APMIS; 1999 Sep; 107(9):869-74. PubMed ID: 10519324
[TBL] [Abstract][Full Text] [Related]
6. Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.
Mavenyengwa RT; Maeland JA; Moyo SR
Clin Vaccine Immunol; 2008 Sep; 15(9):1420-4. PubMed ID: 18667639
[TBL] [Abstract][Full Text] [Related]
7. Serotype markers in a Streptococcus agalactiae strain collection from Zimbabwe.
Mavenyengwa RT; Maeland JA; Moyo SR
Indian J Med Microbiol; 2010; 28(4):313-9. PubMed ID: 20966561
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of Streptococcus agalactiae strains deficient in alpha-like protein encoding genes.
Gabrielsen C; Mæland JA; Lyng RV; Radtke A; Afset JE
J Med Microbiol; 2017 Jan; 66(1):26-33. PubMed ID: 28032541
[TBL] [Abstract][Full Text] [Related]
9. Immunological markers of the R4 protein of Streptococcus agalactiae.
Maeland JA; Bevanger L; Lyng RV
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
[TBL] [Abstract][Full Text] [Related]
10. Determination of epidemiological relationships of Streptococcus agalactiae isolated from bovine mastitis.
Merl K; Abdulmawjood A; Lämmler C; Zschöck M
FEMS Microbiol Lett; 2003 Sep; 226(1):87-92. PubMed ID: 13129612
[TBL] [Abstract][Full Text] [Related]
11. Serotype IX, a Proposed New Streptococcus agalactiae Serotype.
Slotved HC; Kong F; Lambertsen L; Sauer S; Gilbert GL
J Clin Microbiol; 2007 Sep; 45(9):2929-36. PubMed ID: 17634306
[TBL] [Abstract][Full Text] [Related]
12. The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies.
Moyo SR; Maeland JA; Lyng RV
APMIS; 2001 Dec; 109(12):842-8. PubMed ID: 11846725
[TBL] [Abstract][Full Text] [Related]
13. Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci.
Flores AE; Chhatwal GS; Hillier SL; Baker CJ; Ferrieri P
Curr Microbiol; 2014 Dec; 69(6):894-8. PubMed ID: 25108378
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
15. Distribution of serovariants of group B streptococci in isolates from England and Norway.
Kvam AI; Efstratiou A; Bevanger L; Cookson BD; Marticorena IF; George RC; Maeland JA
J Med Microbiol; 1995 Apr; 42(4):246-50. PubMed ID: 7707331
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.
Kong F; Gowan S; Martin D; James G; Gilbert GL
J Clin Microbiol; 2002 Feb; 40(2):620-6. PubMed ID: 11825981
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
18. Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.
Kong F; Lambertsen LM; Slotved HC; Ko D; Wang H; Gilbert GL
J Clin Microbiol; 2008 Aug; 46(8):2745-50. PubMed ID: 18562579
[TBL] [Abstract][Full Text] [Related]
19. The Streptococcus agalactiae R3 surface protein is encoded by sar5.
Basson A; Olaisen C; Selvik LK; Lyng RV; Lysvand H; Gidon A; Aas CG; Afset JE; Dragset MS
PLoS One; 2022; 17(7):e0263199. PubMed ID: 35905090
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
